Wednesday, July 23, 2008

Spotlight on emerging Columbus Tech Companies

OncoImmune, Ltd.

Develops novel therapeutics for cancer and multiple sclerosis through research in functional genomics, immunology and oncology. Focuses on developing innovative concepts from a strong portfolio of proprietary research by its four founders, prominent scientists from The Ohio State University and the University of Michigan.


Accelerates the discovery of new drugs by enabling scientists to achieve excellence in functional genomic research. Scientists come to Phylogeny for help in determining the function of various genes involved in diseases such as cancer, arthritis, and Alzheimer’s disease.

Labels: , , ,


Post a Comment

Subscribe to Post Comments [Atom]

<< Home